Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
- PMID: 17560903
- DOI: 10.1016/j.amjsurg.2006.06.051
Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
Abstract
Background: Long-term survival after hepatectomy for hepatocellular carcinoma is still poor because of tumor recurrence especially in the liver remnant. The risk factors for intrahepatic recurrence after liver resection are studied in our cohort of patients.
Methods: A retrospective analysis from a prospective database was performed on 76 consecutive successful hepatectomies for hepatocellular carcinoma.
Results: Twenty-two patients had intrahepatic recurrence. The following were not found to be risk factors for recurrence: age, sex, race, number of segments resected, and mean operating time. By using multivariate analysis, serum aspartate transaminase level, more than 1 hepatocellular carcinoma nodule, and presence of tumor thrombi were found to be significant risk factors.
Conclusion: Patients who with these risk factors should undergo close follow-up to detect recurrence early; treatment with reresection, chemoembolization, or radiofrequency ablation can be considered.
Similar articles
-
Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.Ann Surg Oncol. 2008 Feb;15(2):618-29. doi: 10.1245/s10434-007-9671-6. Epub 2007 Nov 15. Ann Surg Oncol. 2008. PMID: 18004628
-
Long-term outcomes after hepatectomy for recurrences after prior local ablation for hepatocellular carcinoma.Eur J Surg Oncol. 2008 Apr;34(4):433-8. doi: 10.1016/j.ejso.2007.03.018. Epub 2007 May 1. Eur J Surg Oncol. 2008. PMID: 17475439
-
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.Surgery. 2007 Mar;141(3):330-9. doi: 10.1016/j.surg.2006.06.028. Epub 2006 Nov 1. Surgery. 2007. PMID: 17349844
-
Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.J Hepatobiliary Pancreat Surg. 2008;15(6):589-95. doi: 10.1007/s00534-007-1288-4. Epub 2008 Nov 7. J Hepatobiliary Pancreat Surg. 2008. PMID: 18987928 Review.
-
New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients.J Surg Oncol. 2003 Sep;84(1):36-44; discussion 44. doi: 10.1002/jso.10281. J Surg Oncol. 2003. PMID: 12949989 Review.
Cited by
-
Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study.World J Surg Oncol. 2020 Jun 3;18(1):121. doi: 10.1186/s12957-020-01885-w. World J Surg Oncol. 2020. PMID: 32493393 Free PMC article.
-
Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review.World J Surg Oncol. 2016 Jun 9;14(1):159. doi: 10.1186/s12957-016-0912-7. World J Surg Oncol. 2016. PMID: 27282382 Free PMC article.
-
Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.Br J Radiol. 2018 Oct;91(1090):20180177. doi: 10.1259/bjr.20180177. Epub 2018 Jul 5. Br J Radiol. 2018. PMID: 29927634 Free PMC article.
-
Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection.Korean J Hepatobiliary Pancreat Surg. 2011 May;15(2):83-9. doi: 10.14701/kjhbps.2011.15.2.83. Epub 2011 May 31. Korean J Hepatobiliary Pancreat Surg. 2011. PMID: 26421022 Free PMC article.
-
Do low skeletal muscle bulk and disturbed body fat mass impact tumor recurrence in stage I/II hepatocellular carcinoma undergoing surgery? An observational cohort study.Int J Surg. 2024 Nov 1;110(11):7067-7079. doi: 10.1097/JS9.0000000000001905. Int J Surg. 2024. PMID: 38959093 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical